HGF Presents

Introducing HGF Presents, an exclusive series of concise, high-quality videos. This carefully curated series provides essential insights into a range of topics in EP law and practice, designed to keep you informed and ahead of the curve. Our specialists in each field will guide you through the key legal issues, highlight potential pitfalls and provide practical advice, helping you to navigate the complexities of EP law.

Series 1 covers Patentability of AI Inventions at the EPO, Diagnostic Methods, Unclear Claim Parameters, and Undisclosed Disclaimers. These videos are available for download, allowing you to review them at your convenience.

For more information and to see our recent legal updates please click here.

Series 1 now available for download

Available now for Series 1:

  • Patentability of AI
  • Diagnostic Methods
  • Unclear Claim Parameters
  • Undisclosed Disclaimers

Series 2 coming 7th April:

  • Overview of Oppositions and Appeals at the EPO
  • Regulatory Exclusivity for Medical Products in Europe
  • Priority
  • Bioinformatics

Latest legal updates

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article

Can intellectual property and foreign investment save struggling European eVTOL companies?

With the ongoing funding difficulties in the European eVTOL sector, we look at the role that intellectual property is likely to play in the prospects for the survival of Lilium …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article